Info for Research Professionals

Ameriderm Research, the ADCS Clinical Research Division, is a new model for academic medicine, a clinical researching division without walls. ADCS is the largest dermatology group practice in the US, with over 50 offices in Florida. Over 400,000 patients are seen per year. These patients represent nearly every age group and every demographic. Patients can be completely healthy coming for aesthetic services to having multiple skin and systemic disease disorders. Ameriderm Research was established to make available to this vast patient population base the Clinical Trials that could provide with access to new drugs and treatments. Moreover, the division helps the pharmaceutical and device industry gain access to this diverse and extensive patient base.

Currently we have over 20 studies going at 3 clinical trial sites. But this is just the beginning. The plan is to have multiple regional sites who can draw on recruitment not only form the site itself but from nearby ADCS offices. In addition, to pharmaceutical based Clinical Trials, Ameriderm Research is involved with various Universities to cooperate on more basic level clinical studies which help elucidate disease processes, mechanics and pharmacology of treatment response, pathology of disorders, and new high tech data management and device development. Ameriderm Research works with various cosmetic companies to draft and run protocols to test new product development as well as to compare products with competitors. Finally, Ameriderm Research plays a fundamental role to link several universities’ students and medical residents to dermatology training programs and research opportunities within ADCS.